Feasibility and safety of robotic-assisted pancreatectomy for pancreatic tumor

Phase 2

Suspended

• Conditions: pancreatic neoplasms; pancreatic tumor

• Registration Number: JPRN-jRCTs022180048
• Lead Sponsor: Ishido Keinosuke

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-03-26
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Suspended
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Age: From 20y.o. to 85y.o.
Disease
1. pancreatic benign tumor
2. pancreatic neuroendocrine tumor
3. IPMN
4. pancreatic cystic tumor
5. pancreatic duct adenocaricnoma (classified as Resectable)

Exclusion Criteria

1. Unresectable pancreatic cancer
2. Borderline resectable pancreatic cancer
3. Poor performance status
4. Case which is not appropriate for this clinical study
5. Case in which informed consent is not obtained

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Morbidity rate exceeding Grade 3 in Clavien-Dindoclaasification

Secondary Outcome Measures

Name	Time	Method
1. hospital stay<br>2. conversion rate<br>3. number of dissected lymph nodes<br>4. R0 resection rate<br>5. postoperative quality of life (SF-36)